Female breast nipple and areola cancer is a rare breast cancer that starts in the nipple or the darker skin around it. Early symptoms of female breast nipple and areola cancer can include nipple crusting, itching, burning, pain, discharge, or a sore that does not heal. Many people first hear about female breast nipple and areola cancer after changes that look like eczema keep coming back or affect only one breast. It most often affects adults, especially older women, and it does not go away without treatment. The outlook depends on how far the cancer has spread, and treatment often includes surgery and may also include radiation, chemotherapy, hormone therapy, or targeted therapy.
How many people live with Female breast nipple and areola cancer?
Worldwide, about 7.8 million women were living within 5 years of a breast cancer diagnosis at the end of 2022 (WHO, 2024); because cancer in the nipple or the darker skin around it is rare and is usually estimated to make up about 1% to 3% of breast cancers, that suggests roughly 78,000 to 234,000 women worldwide may be living with this form, but this is an estimate rather than a direct count. In the United States, more than 4 million women are living with a history of breast cancer (American Cancer Society, 2024), so the same 1% to 3% range suggests about 40,000 to 120,000 may be living with nipple or areola breast cancer, again as an estimate rather than a direct count.
Overview
Female breast nipple and areola cancerSymptoms
Female breast nipple and areola cancer can cause a new nipple rash, itching, pain, or burning. Some notice crusting, flattening, discharge, or bleeding. Early symptoms of Female breast nipple and areola cancer can look like eczema that does not heal.
Outlook and prognosis
Many people with female breast nipple and areola cancer do well when it is found early. Outlook depends on the stage, whether nearby tissue or lymph nodes are involved, and the cancer type, including Paget disease or an underlying breast tumor.
Causes and risk factors
Female breast nipple and areola cancer is linked to older age, inherited gene changes such as BRCA1 or BRCA2, and a personal or family history of breast cancer. Risk may also rise with obesity, alcohol use, and prior chest radiation.
Genetic influences
Genetics can matter in female breast nipple and areola cancer, but most cases are not caused by a single inherited change. Some people have a higher risk because of family-linked gene variants, which may guide testing and treatment choices.
Diagnosis
Female breast nipple and areola cancer is diagnosed with a breast exam and imaging, often a mammogram or ultrasound. Doctors usually confirm the diagnosis with a biopsy. Early symptoms of female breast nipple and areola cancer can guide testing.
Treatment and drugs
Female breast nipple and areola cancer is usually treated with surgery to remove the cancer, often followed by radiation. Depending on the tumor, some women also need chemotherapy, hormone-blocking medicine, or targeted drugs. Treatment is tailored to stage and spread.
Symptoms
Changes in the nipple or the darker skin around it can affect comfort, clothing, and day-to-day routines long before people think of cancer. Female breast nipple and areola cancer often starts with skin changes on one side that do not settle down like a simple rash. You might notice small changes at first, and the early symptoms of female breast nipple and areola cancer can be mistaken for irritation or eczema.
The nipple or areola may look red, scaly, flaky, or crusted. The skin can seem irritated or develop a rash that keeps coming back or does not heal.
Many living with female breast nipple and areola cancer notice itching, tingling, or a burning feeling in the nipple area. This can be mild at first but may become more persistent over time.
Fluid from the nipple can be clear, yellowish, or bloodstained. Discharge that happens without squeezing, especially from one breast, is more concerning.
The nipple or areola may ooze, weep, or bleed from broken skin. Some may find that bras or shirts stick to the area because of crusting or moisture.
How people usually first notice Female breast nipple and areola cancer?
Many people first notice female breast nipple and areola cancer when the nipple or the darker skin around it starts to look different and does not heal, with changes such as redness, scaling, crusting, itching, burning, or oozing that can seem a lot like a stubborn skin rash. Some living with this cancer also notice a new lump in the breast, nipple flattening or turning inward, unusual discharge that may be bloody, or skin thickening in the area. Because these first signs of female breast nipple and areola cancer can look mild at first, especially when they come and go, changes that persist for more than a few weeks should be checked by a clinician.
Types of Female breast nipple and areola cancer
No distinct types of female breast nipple and areola cancer are widely recognized.
Can I slow down the onset of symptoms?
No, there is no proven way to meaningfully slow or delay the start of symptoms from cancer of the nipple and the darker skin around it once it is developing. Healthy habits such as staying at a healthy weight, limiting alcohol, being physically active, and not smoking may lower the overall risk of some breast cancers, but they have not been shown to specifically delay symptoms of this uncommon type, and they cannot prevent it. Regular breast screening when recommended for your age and risk, and getting nipple changes checked early, can help find cancer sooner, which may improve treatment options even though it cannot guarantee prevention.
What genetics can tell you about symptoms
For cancer of the nipple and areola, genetics can sometimes help explain overall cancer risk, but they usually do not clearly predict exactly which symptoms someone will notice day to day. Inherited gene changes linked to breast cancer risk, such as BRCA1 or BRCA2, may raise the chance of developing cancer, while changes in the cancer cells themselves can affect how quickly the cancer grows and, in some cases, how early symptoms begin or how severe they become. Even so, symptoms such as nipple itching, burning, scaling, discharge, pain, or changes in the skin often depend more on the exact type of cancer and how far it has spread than on genetics alone.
Causes and risk factors
Risk rises with age and with a personal or family history of breast cancer. Inherited gene changes, including BRCA1 and BRCA2, can also raise the chance of female breast nipple and areola cancer. Past radiation to the chest and longer lifetime exposure to estrogen, such as early periods or late menopause, may play a role. Some risks are modifiable, or things you can change, and others are non-modifiable, or things you cannot. Among the main risk factors for female breast nipple and areola cancer are alcohol use, excess body weight after menopause, and low physical activity.
What are the most common causes or risk factors?
The exact cause is usually not clear, but cancer in the nipple or areola is often linked to a breast cancer that starts in the tissue under or near the nipple. Risk is higher with older age, a strong family history of breast cancer, or inherited gene changes such as BRCA1 or BRCA2. Other common risk factors include having had breast cancer before, having more years of exposure to estrogen over a lifetime, being overweight after menopause, drinking alcohol, and past radiation treatment to the chest.
Environmental and biological risk factors
Female breast nipple and areola cancer is uncommon, and its risk factors mostly overlap with those of breast cancer more broadly. Many cases are linked to changes in breast tissue behind the nipple, so body-based factors and certain outside exposures both matter. Doctors often group risks into internal (biological) and external (environmental).
Risk rises with age, especially after menopause. That is one reason female breast nipple and areola cancer is diagnosed more often in later adult life.
Dense breast tissue can slightly raise the chance of breast cancer and can also make cancers harder to see on a mammogram. This matters because a cancer that reaches the nipple or areola often starts deeper in the breast.
Having had breast cancer before increases the chance of another breast cancer developing later. This can include female breast nipple and areola cancer or a cancer in another part of the breast.
Certain findings on a past breast biopsy, such as marked overgrowth of abnormal-looking cells, are linked with a higher future breast cancer risk. These changes do not mean cancer is already present, but they do signal higher risk.
Genetic risk factors
Seeing breast cancer in close relatives can make the risk feel very personal, even before anyone has symptoms. Because female breast nipple and areola cancer is rare, doctors usually look at the same inherited patterns seen in breast cancer overall. Some risk factors are inherited through our genes. The strongest clues are a cancer-related gene change or a family history of breast, ovarian, pancreatic, or prostate cancer.
BRCA1 changes: Inherited BRCA1 changes are among the strongest known genetic risk factors for breast cancer. For female breast nipple and areola cancer, doctors generally consider BRCA1 relevant because the same breast tissue is involved.
BRCA2 changes: BRCA2 changes also raise the chance of breast cancer and can run through several generations. Families with breast, ovarian, pancreatic, or prostate cancer may be offered testing for BRCA2.
PALB2 changes: PALB2 is another inherited breast cancer gene linked to a clearly higher risk. In some families, a PALB2 change may help explain female breast nipple and areola cancer when BRCA1 and BRCA2 testing is negative.
TP53 syndrome: TP53 changes cause Li-Fraumeni syndrome, a rare inherited condition linked to several cancers, including early breast cancer. This risk is especially considered when breast cancer appears at a young age or alongside sarcoma, brain, or adrenal tumors.
PTEN syndrome: PTEN changes can cause Cowden syndrome, which raises breast cancer risk and often comes with thyroid disease, a larger head size, or multiple noncancerous growths. When these clues travel together in a family, inherited PTEN risk becomes more likely.
CDH1 changes: CDH1 changes are best known for hereditary diffuse gastric cancer, but they also increase the risk of lobular breast cancer. That link can matter when doctors assess genetic risk factors for female breast nipple and areola cancer in families with stomach cancer and breast cancer together.
Family history: A strong family history is often the biggest clue that inherited risk may be present, even before genetic testing is done. Breast cancer in several close relatives, especially at younger ages or in both breasts, makes an inherited cause more likely.
Ancestry patterns: Some ancestry groups have founder variants, which are gene changes passed down from a distant common ancestor. For example, BRCA1 and BRCA2 changes are more common in people of Ashkenazi Jewish ancestry.
Other genes: Other inherited genes, such as CHEK2, ATM, STK11, and NF1, can also raise breast cancer risk, although usually less than BRCA1 or BRCA2. A genetics specialist may consider these when female breast nipple and areola cancer appears in a family without a clear cause.
Lifestyle risk factors
Some everyday habits can influence the chance of developing cancer in the nipple and areola area because these tumors are usually part of breast cancer biology. The most established lifestyle risk factors for female breast nipple and areola cancer include alcohol use, excess body weight after menopause, low physical activity, smoking, and certain hormone-related choices. When people ask about lifestyle risk factors for female breast nipple and areola cancer, the strongest evidence points to patterns that affect estrogen exposure, inflammation, and overall breast tissue health.
Drinking alcohol raises breast cancer risk, and the risk tends to increase as intake goes up. Alcohol can affect estrogen levels and may damage DNA in breast cells.
Being overweight or having obesity, especially after menopause, is linked to a higher risk of breast cancers that can involve the nipple and areola. Extra body fat can increase estrogen production and promote chronic inflammation.
Too little physical activity is associated with a higher breast cancer risk. Regular exercise helps with weight control, hormone balance, and insulin regulation, which may lower risk.
Smoking may increase breast cancer risk, particularly with long-term or earlier-life exposure. Tobacco smoke contains carcinogens that can damage breast tissue over time.
Risk prevention
Female breast nipple and areola cancer cannot always be prevented, because some cases happen without a clear avoidable cause. Prevention is about lowering risk, not eliminating it completely. For many, this means lowering the chance of breast cancer overall, since cancers affecting the nipple and areola are often linked to changes deeper in the breast. It also helps to know the early symptoms of breast nipple and areola cancer, such as new nipple crusting, discharge, flattening, or skin changes that do not go away.
Keeping a healthy weight, especially after menopause, can lower breast cancer risk. Regular movement and balanced eating help reduce hormone and inflammation changes that can affect breast tissue.
Drinking less alcohol can reduce the risk of female breast nipple and areola cancer and other breast cancers. If you drink, even small reductions may help over time.
Not smoking and avoiding secondhand smoke support overall breast health. Smoking may raise breast cancer risk, especially over many years.
Some menopausal hormone therapy plans can raise breast cancer risk, particularly when used for longer periods. Talk to your doctor about the lowest effective dose, shorter use, or non-hormonal options if symptoms allow.
Can you prevent Female breast nipple and areola cancer?
You cannot fully prevent cancer of the nipple and areola, and there is no sure way to stop it from happening. Still, some steps may help lower overall breast cancer risk, including limiting alcohol, staying physically active, keeping a healthy weight, and talking with your doctor about the risks and benefits of hormone therapy after menopause.
Transmission
Female breast nipple and areola cancer is not infectious and cannot be passed from one person to another through touch, kissing, sex, shared food, or the air. Many people wonder whether nipple and areola cancer is contagious, but the cancer itself does not spread between people.
What can be passed down is a higher inherited risk of breast cancer, so some people develop this cancer partly because of gene changes inherited from a parent, while others do not have a clear family link. If the cancer spreads to nearby tissue or other parts of the body, that is cancer spreading within the body, not transfer to someone else.
When to test your genes
Consider genetic testing if you have breast cancer involving the nipple or areola at a young age, triple-negative disease, cancer in both breasts, or a strong family history of breast, ovarian, pancreatic, or prostate cancer. Results can guide screening, surgery choices, and whether targeted treatments such as PARP inhibitors may help.
Diagnosis
Changes in the nipple or areola, such as persistent redness, scaling, itching, discharge, or a sore that does not heal, are often what first lead people to seek care for female breast nipple and areola cancer. Because these changes can look like eczema, infection, or skin irritation, diagnosis usually involves a breast exam along with imaging and a tissue sample. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of female breast nipple and areola cancer is made by combining what the doctor sees with what tests show.
Doctors usually begin by asking when the nipple or areola changes started and whether there is pain, discharge, bleeding, or a lump in the breast. A detailed family and health history can help show whether breast cancer risk factors may also be present.
A clinician checks the nipple, areola, and surrounding breast skin for crusting, thickening, ulceration, or flattening of the nipple. They also feel the breast and underarm area to look for a mass or enlarged lymph nodes.
Mammography and breast ultrasound are common first tests to look for an underlying breast tumor or other suspicious changes. If these do not fully explain the symptoms, your provider may suggest breast MRI to look closer.
A small sample from the nipple or areola is often needed when the skin changes persist or look suspicious. Under the microscope, this can show cancer cells in the skin and help confirm how female breast nipple and areola cancer is diagnosed.
How is Female breast nipple and areola cancer diagnosed?
Female breast nipple and areola cancer is usually diagnosed after a doctor examines the breast and checks the nipple changes, then orders breast imaging, most often a mammogram and sometimes an ultrasound or MRI scan, especially if there is crusting, discharge, pain, or a lump. The diagnosis is confirmed with a biopsy, which means taking a small sample of skin or breast tissue from the nipple, areola, or any lump and looking at it under a microscope for cancer cells. Genetic testing does not usually make the diagnosis, but some women may later have testing of the tumor or inherited genes to help guide treatment and check family risk.
Stages of Female breast nipple and areola cancer
Female breast nipple and areola cancer is usually described by cancer stage rather than by a step-by-step pattern of symptoms over time. The stage tells you how much cancer is present, whether it is only in the nipple or nearby breast tissue, and whether it has spread to lymph nodes or other parts of the body. Doctors usually start with a conversation about skin changes, nipple symptoms, imaging, and a biopsy, because early symptoms of female breast nipple and areola cancer can look like a stubborn rash or irritation at first.
Stage 0
Abnormal cells are limited to the surface area or milk ducts and have not grown into deeper tissue. This is a very early stage. Treatment is often highly effective.
Stage 1
The cancer is small and has grown into nearby breast tissue, but spread is limited or not found. Lymph nodes are either clear or only minimally involved. Many people feel relief once they understand what’s happening.
Stage 2
Female breast nipple and areola cancer is larger or has spread to a small number of nearby lymph nodes. It is still considered potentially curable. Treatment often involves a mix of surgery and other therapies.
Stage 3
Female breast nipple and areola cancer has spread more extensively in the breast, skin, chest wall, or nearby lymph nodes. It has not spread to distant organs. Care is usually more intensive and may begin before surgery.
Stage 4
Female breast nipple and areola cancer has spread to distant parts of the body, such as bone, liver, lung, or brain. At this stage, treatment focuses on controlling the cancer, easing symptoms, and helping people live as well as possible. Many living with advanced disease can still have meaningful response to treatment for long periods.
Outlook and prognosis
Outlook for female breast nipple and areola cancer depends mainly on whether the disease is confined to the nipple-areola complex or is associated with an underlying invasive breast cancer and lymph node spread. When found early and treated appropriately, prognosis is often favorable, and patients with localized disease generally have high long-term survival, with 5-year survival commonly above 90% in early-stage cases. Outcomes are less favorable when there is an invasive tumor beneath the nipple, positive lymph nodes, or distant metastasis. Mortality is therefore low for localized disease but rises substantially in advanced or metastatic cancer. Careful staging, surgery, and any needed radiation, endocrine therapy, chemotherapy, or targeted therapy strongly influence the individual outlook.
Long-term effects
Female breast nipple and areola cancer can have lasting effects that depend on how far the cancer spread and what treatment was needed. For many, the long-term picture is often shaped as much by surgery, radiation, and drug treatment as by the cancer itself. Some people do very well for years, while others need ongoing checks for recurrence, new breast changes, or treatment-related health problems. Thinking about the long-term effects helps explain why follow-up care may continue long after treatment ends.
One of the main long-term concerns is the cancer coming back in the nipple, areola, breast, nearby lymph nodes, or elsewhere in the body. The outlook is usually better when female breast nipple and areola cancer is found early, before deeper breast tissue or lymph nodes are involved.
Lasting changes in breast shape, firmness, skin texture, or nipple appearance are common after treatment. Some may find bras, fitted clothing, or lying on the treated side feel different for a long time.
Ongoing tenderness, burning, tightness, or numb areas can happen after surgery or radiation. These changes may be mild, but for some living with female breast nipple and areola cancer, they can affect sleep, exercise, or daily comfort.
If lymph nodes were removed or treated with radiation, some people develop lymphedema, which is swelling in the arm, breast, chest wall, or hand. It can appear months or even years later and may cause heaviness, tightness, or reduced range of motion.
How is it to live with Female breast nipple and areola cancer?
Living with female breast nipple and areola cancer can touch daily life in ways that are both physical and deeply personal, because changes in the breast are not only symptoms to manage but also part of how many people experience body image, intimacy, and confidence. Some people live with pain, tenderness, itching, discharge, fatigue from treatment, or worry around scans and appointments, while everyday routines may shift around surgery, radiation, or medicines and the recovery that follows. It can also affect partners, children, and other loved ones, who may take on caregiving roles, share the emotional strain, and need honest conversations about support, but with good treatment and a strong care team, many people find ways to protect their routines, relationships, and sense of self through the process.
Treatment and drugs
Female breast nipple and areola cancer is usually treated with surgery, and the exact plan depends on how deep the cancer goes, whether it has spread, and whether there is cancer elsewhere in the breast. Treatment often looks different for each person, but many people have surgery to remove the nipple and areola and sometimes part or all of the breast, with a check of nearby lymph nodes to see if cancer cells have traveled. Some living with female breast nipple and areola cancer also need radiation therapy, especially after breast-conserving surgery, and some may be offered medicines such as hormone-blocking treatment, chemotherapy, or targeted drugs based on the tumor’s test results. Doctors choose these treatments to lower the chance of the cancer coming back and to treat disease that may be too small to see on scans. If you are learning about treatment options for female breast nipple and areola cancer, it can help to ask how surgery, radiation, and drug treatment may affect healing, appearance, and daily life.
Can you cure Female breast nipple and areola cancer?
Sometimes, yes, this cancer can be cured, especially if it is found early and has not spread beyond the breast area. Treatment often involves surgery, and some people also need radiation, medicines that target cancer cells, or both to lower the chance of the cancer coming back. If it has spread, treatment may not cure it, but it can often help control the cancer, slow it down, and ease symptoms.
Non-drug treatment
For many living with female breast nipple and areola cancer, treatment often centers on procedures and supportive care rather than medicines alone. The main non-drug treatments are surgery and, in some cases, radiation, with added therapies to help recovery, comfort, and body image. Managing this condition often means tailoring care to the size of the cancer, whether it has spread into the breast, and your personal goals.
Surgery is the main treatment for female breast nipple and areola cancer. Some people can have breast-conserving surgery that removes the nipple-areola area and the cancer, while others need a mastectomy to remove the whole breast.
Many people with female breast nipple and areola cancer also need nearby lymph nodes checked during surgery. This helps show whether the cancer has spread and guides what treatment is most appropriate next.
Radiation may be used after breast-conserving surgery to lower the chance of the cancer coming back in the breast area. For some people, radiation therapy after surgery for nipple and areola cancer is a standard part of treatment.
Reconstruction can rebuild the shape of the breast, nipple, or areola after cancer surgery. This may be done at the same time as surgery or later, depending on your treatment plan and preferences.
Your genes may have an impact on how drugs work for you
For people living with cancer of the nipple and areola, genes can sometimes affect how well certain treatments work and how likely side effects are. In some cases, inherited differences change how the body breaks down common cancer medicines, while changes inside the cancer itself can help doctors choose treatments that are more likely to work, such as hormone-blocking or other targeted medicines. This kind of gene-based treatment matching is part of what is called pharmacogenomics, and it may help your care team avoid medicines that are less effective or more likely to cause harm.
Pharmacological treatments
Medicine treatment for female breast nipple and areola cancer depends mostly on the breast cancer type, stage, and whether the cancer cells are driven by hormones or HER2. Many living with female breast nipple and areola cancer receive drug treatment before surgery, after surgery, or for cancer that has spread. Some medicines work throughout the body to lower the chance of the cancer coming back, while others target a specific cancer signal more directly.
Common chemotherapy drugs include doxorubicin, epirubicin, cyclophosphamide, paclitaxel, and docetaxel. These medicines are often used before or after surgery, and they may also be used when female breast nipple and areola cancer has spread.
If the cancer is hormone receptor-positive, drugs such as tamoxifen, anastrozole, letrozole, or exemestane may help block estrogen or lower its levels. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy).
For HER2-positive disease, trastuzumab and pertuzumab are widely used, and some people may also receive ado-trastuzumab emtansine or trastuzumab deruxtecan. These medicines target a growth signal on the cancer cells more precisely than standard chemotherapy alone.
Pembrolizumab may be used for some triple-negative breast cancers, especially in higher-risk early disease or in advanced cancer. Not everyone responds to the same medication in the same way.
Genetic influences
For many women, questions about female breast nipple and areola cancer become more urgent when a mother, sister, or several relatives have had breast or ovarian cancer. The inherited risk factors are generally the same ones linked to breast cancer more broadly: most cases are not caused by a single gene, but some are linked to variants such as BRCA1, BRCA2, or PALB2. Having a genetic risk is not the same as having the disease itself. Doctors may look more closely at genetics when cancer develops at a younger age, affects both breasts, or appears in several close relatives, sometimes along with ovarian, pancreatic, or prostate cancer in the family. If female breast nipple and areola cancer is diagnosed, genetic testing can sometimes help guide treatment and tell relatives whether they may benefit from counseling or earlier screening. If you are concerned about the genetic risk of female breast nipple and areola cancer, asking about your family pattern is a practical first step.
Is Female breast nipple and areola cancer genetic?
Genetics can matter in female breast nipple and areola cancer, but most cases are not caused by a single inherited change. Some people have a higher risk because of family-linked gene variants, which may guide testing and treatment choices.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal and common part of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant connected to a condition points to a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for female breast nipple and areola cancer is often shaped not just by where the cancer is, but by the gene changes found in the tumor itself. Doctors may test the cancer for markers such as HER2 and hormone-related changes because these results can show whether targeted medicines or hormone-blocking treatment are more likely to help, or whether standard chemotherapy may be needed. Some people with female breast nipple and areola cancer also have an inherited change in genes such as BRCA1 or BRCA2, which can open the door to certain targeted drugs and may also affect surgical planning for the breast and ovaries.
Beyond trial and error, genetics offers another way to match treatment more closely to the cancer. In some cases, tests on the tumor can help estimate how much benefit chemotherapy is likely to add, which can spare many living with female breast nipple and areola cancer from treatment that may not help much. Inherited genetics can sometimes matter for drug safety too, since a small number of people process certain cancer medicines differently and may need closer monitoring or a dose change. That is one reason why how genetic testing affects treatment for female breast nipple and areola cancer is often part of the discussion early in care.
Interactions with other conditions
People living with female breast nipple and areola cancer may also be dealing with other breast conditions, skin changes, or long-term health problems that can make symptoms harder to sort out. For example, redness, scaling, pain, or discharge from the nipple can sometimes overlap with eczema, infection, or other breast cancers, so doctors often need imaging and a biopsy to tell them apart. This is especially important because early symptoms of female breast nipple and areola cancer can look like a rash that does not heal. Many people live with more than one health issue at a time. Other illnesses can also affect treatment choices for female breast nipple and areola cancer; heart disease, diabetes, immune system problems, or poor wound healing may influence whether surgery, radiation, or medicines are the safest option. If the cancer has spread, it can interact with bone, liver, or lung disease and add to symptoms such as pain, fatigue, or shortness of breath, so care is often tailored to the whole picture, not just the tumor.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Female breast nipple and areola cancer?
Eczema or skin irritation, psoriasis, and breast or nipple infections such as mastitis can all cause redness, itching, flaking, crusting, soreness, or discharge that looks a lot like nipple and areola cancer. Some noncancerous breast problems, including blocked milk ducts or harmless nipple growths, can also cause discharge, skin changes, or a lump. Because these problems can look very similar at first, especially when only one nipple is affected, a doctor often needs to examine the area and sometimes do tests to tell the difference.
History
Throughout history, people have described unusual changes of the nipple and the darker skin around it, even when they did not yet understand that some of these changes could be linked to breast cancer. People living with female breast nipple and areola cancer may first notice symptoms that seem easy to dismiss, such as persistent redness, crusting, itching, or a sore spot that does not heal. In earlier times, these skin changes were often mistaken for irritation, eczema, or infection, which helps explain why diagnosis could be delayed.
In the 19th century, doctors began publishing clearer medical descriptions of nipple changes that appeared alongside cancers deeper in the breast. This was an important turning point, because it showed that a rash-like problem on the nipple was not always just a skin condition. Over time, female breast nipple and areola cancer became better recognized as part of a broader group of breast cancers, rather than a separate minor problem affecting only the surface.
As medical science evolved, doctors improved the way they examined the breast, the nipple, and the areola, and tissue testing helped confirm when cancer cells were present. Imaging later made it easier to look for disease inside the breast as well, even in someone whose main complaint was nipple discharge or a scaly patch that kept coming back. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, awareness has grown that early symptoms of female breast nipple and areola cancer can be subtle and may overlap with common noncancerous skin problems. This has led to a more careful approach: when nipple changes do not improve, doctors are more likely to consider testing rather than assuming the cause is harmless. Researchers later identified that some breast cancers, including those affecting the nipple and areola, can arise from changes in cells and may behave differently from one person to another. Knowing the condition’s history helps explain why persistent nipple or areola changes deserve medical attention, even when they seem mild at first.